autistic disorder
The 285-gene panel tests for conditions associated with autism and intellectual disability and can be taken at home via a saliva swab.
Bionano Genomics Acquires Diagnostic Services Provider Lineagen for $9.6M
The deal consists of cash, Bionano common stock, and assumption of liabilities. Bionano has also paid off $1.1 million loaned to Lineagen under the CARES act.
Quadrant Biosciences Gets $330K NIH Grant to Continue Autism Dx Test Development
The new grant will be used to conduct whole-exome sequencing on 1,000 children participating in an autism spectrum disorder study for the purposes of biomarker development.
Companies are developing metabolomic tests both to aid in early diagnosis of the condition and to help guide treatment in patients with metabolic imbalances.
Lineagen Taps PWNHealth to Increase Consumer Access to Genetic Tests
Lineagen hopes to use PWNHealth's consumer-oriented model to expand access to its testing services for developmental delay and autism spectrum disorder.